Hana Asset Management's '1Q U.S. Medical AI' ETF Achieves ₩3.4 Billion Purchase on Debut Day
Hana Asset Management's '1Q U.S. Medical AI' ETF garnered a significant personal net purchase of ₩3.4 billion on its first trading day, marking it as the top-performer among U.S. stock ETFs set for listing in 2025. The ETF strategically invests in 15 companies expected to excel within the healthcare AI sector, notably featuring TempusAI, Recursion Pharmaceuticals, and Intuitive Surgical. Additionally, it includes global giants such as Google and Novartis, highlighting its diverse portfolio.
CEO Kim Tae-woo anticipates sustained growth within the medical AI industry and foresees ongoing AI investments primarily focused on the U.S. market. TempusAI stands out by launching multiple FDA-approved diagnostic software, capturing investors' attention. Moreover, a purchase event scheduled for summer 2025 is likely to draw further interest from investors, reflecting its estimated future growth potential.
Related News
Hana Asset '1Q US Medical AI', No.1 in Individual Net Buying on Listing Day - EdailyHana Asset Management announced on the 24th that the '1Q US Medical AI' ETF, which was listed on the 22nd, ranked first in individual net buying among newly listed US stock-type ETFs this year on the first day of listing. According to the Korea Exchange, the individual net buying volume of the 1Q US Medical AI ETF on the first day of listing was about 34...
뉴스핌2025 7月 24
Hana Investment '1Q US Medical AI ETF, Ranked First in Individual Net Purchases on First Day of Listing in US ETFs'- News Pim[Seoul=News Pim] Reporter Ki-uk Song = Hana Asset Management announced on the 24th that the 1Q US Medical AI ETF, which was listed on July 22, recorded 'First Place in Individual Net Purchases on the First Day of Listing among All US Stock ETFs Listed in 2025'. According to the Korea Exchange, the 1Q US Medical AI ETF was listed